Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 121,548 | 107,358 | 88,076 | 96,864 | 92,263 |
| Cost of Goods | 65,738 | 62,527 | 53,210 | 56,512 | 47,246 |
| Gross Profit | 55,810 | 44,831 | 34,866 | 40,352 | 45,017 |
| Operating Expenses | 55,164 | 48,500 | 40,403 | 43,312 | 41,814 |
| Operating Income | 646 | -3,669 | -5,537 | -2,960 | 3,203 |
| Interest Expense | 2,368 | 2,374 | 1,756 | 2,447 | 1,915 |
| Other Income | -195 | -9,567 | 6,894 | 13,282 | -680 |
| Pre-tax Income | -1,917 | -15,610 | -399 | 7,875 | 608 |
| Income Tax | 1,874 | -2,988 | -2,584 | -2,860 | 523 |
| Net Income Continuous | -3,791 | -12,622 | 2,185 | 10,735 | 85 |
| Net Income | $-3,791 | $-12,622 | $2,185 | $10,735 | $85 |
| EPS Basic Total Ops | -0.04 | -0.13 | 0.02 | 0.10 | 0.00 |
| EPS Basic Continuous Ops | -0.04 | -0.13 | 0.02 | 0.10 | 0.00 |
| EPS Diluted Total Ops | -0.04 | -0.13 | 0.02 | 0.10 | 0.00 |
| EPS Diluted Continuous Ops | -0.04 | -0.13 | 0.02 | 0.10 | 0.00 |
| EBITDA(a) | $18,219 | $-1,098 | $12,941 | $24,292 | $15,912 |